Skip to main content

Select Drug Profiles

Original Research, Practice Management, Infectious Diseases
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models
Thomas Lodise, PhD, PharmD, Kenneth LaPensee, PhD, MPH
Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH
Read More
Perspectives
Will We Ever Bend the Cost Curve in Healthcare?
Ehsan U. Syed, MD
Ehsan U. Syed, MD
Read More
FDA Approvals, In the News
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Read More
Commencement 2019
Read More
FDA Approvals, In the News
First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Effect of Fixed-Duration Venetoclax plus Obinutuzumab on Progression-Free Survival and Minimal Residual Disease Status in Treatment-Naïve Patients with CLL and Comorbidities
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Three-Year Follow-Up of Acalabrutinib and Obinutuzumab in Treatment-Naïve and Relapsed/Refractory CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Comparison of 3 Rituximab-Containing Regimens as Primary Therapy in Patients with WM
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Patient-Reported Outcomes with Ibrutinib-Rituximab in WM: Results from iNNOVATE
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Evaluation of MRD with Lisocabtagene Maraleucel, a CD19-Directed CAR T Therapy, in Patients with Relapsed/Refractory CLL/SLL
Read More
Page 51 of 244
Results 501 - 510 of 2438